agilon health (NYSE:AGL) Issues Earnings Results

agilon health (NYSE:AGL) issued its quarterly earnings results on Tuesday. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.07), Zacks reports. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%.

agilon health Trading Up 1.8 %

Shares of agilon health stock traded up $0.07 during midday trading on Tuesday, reaching $3.71. 6,676,662 shares of the company’s stock traded hands, compared to its average volume of 5,254,070. The stock has a 50 day moving average of $2.85 and a 200-day moving average of $3.05. agilon health has a 12 month low of $1.50 and a 12 month high of $7.73. The company has a market cap of $1.53 billion, a PE ratio of -3.94 and a beta of 0.66. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

Analyst Ratings Changes

A number of analysts recently weighed in on AGL shares. Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and boosted their target price for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Barclays lowered their price objective on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a report on Monday, November 11th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $3.00 price objective on shares of agilon health in a research note on Tuesday, November 19th. William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Finally, TD Cowen cut their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, agilon health currently has a consensus rating of “Hold” and an average price target of $4.03.

Insider Buying and Selling at agilon health

In related news, Director Karen Mcloughlin acquired 25,000 shares of the stock in a transaction on Friday, December 13th. The stock was acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the acquisition, the director now directly owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This represents a 51.90 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John William Wulf bought 45,000 shares of agilon health stock in a transaction on Thursday, December 5th. The shares were purchased at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 77,500 shares of company stock valued at $169,600. 3.20% of the stock is currently owned by company insiders.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.